CeutiCare focuses on enhancing patient health outcomes through innovative healthcare technologies and programs. Their offerings include a full-service Chronic Care Management (CCM) and Behavioral Health Integration (BHI) software, which is designed to improve medication management for patients with chronic diseases. The company emphasizes the importance of engaging patients in their own care, which can lead to better health outcomes and reduced healthcare costs. Additionally, CeutiCare has developed specialized programs such as the Secondary Hyperparathyroid Program, which aligns with the latest CMS CCM rules to optimize patient care.

The company also collaborates with various stakeholders, including physicians, pharmacists, hospitals, and payors, to create a network that supports chronic disease management and pain management. Their PharmD Reseller Program aims to expand their reach and impact by partnering with resellers who share their commitment to healthcare innovation. CeutiCare's approach is centered on improving therapeutic outcomes for patients suffering from chronic conditions, showcasing their dedication to transforming healthcare delivery through technology and collaborative partnerships.

United States

CeutiCare improves outcomes and lowers medical costs of treating the chronically ill patient.  CeutiCare's Intelligent Clinical Guidance (ICG) system provides knowledge-based technology to support evaluation of patients by a pharmacist or other physician extender at the patient's point of care.  Our proprietary ICG system evaluates patient clinical data and recommends patient-specific, evidence-based medication therapy to help the patient get better and feel well.

CeutiCare

Company Details